Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more
Compass Pathways Plc (CMPS) - Total Liabilities
Latest total liabilities as of September 2025: $218.02 Million USD
Based on the latest financial reports, Compass Pathways Plc (CMPS) has total liabilities worth $218.02 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Compass Pathways Plc - Total Liabilities Trend (2018–2024)
This chart illustrates how Compass Pathways Plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Compass Pathways Plc Competitors by Total Liabilities
The table below lists competitors of Compass Pathways Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanon Systems
KO:018880
|
Korea | ₩7.51 Trillion |
|
Citic Guoan Wine Co Ltd
SHG:600084
|
China | CN¥144.76 Million |
|
Shenzhen Worldunion Properties Consultancy Inc
SHE:002285
|
China | CN¥1.16 Billion |
|
Comture Corporation
PINK:CMTUF
|
USA | $6.15 Billion |
|
Citra Marga Nusaphala Persada
JK:CMNP
|
Indonesia | Rp8.89 Trillion |
|
China Bills Finance Corp
TW:2820
|
Taiwan | NT$229.84 Billion |
|
Ningxia Building Materials Group Co Ltd
SHG:600449
|
China | CN¥2.60 Billion |
|
Finolex Industries Limited
NSE:FINPIPE
|
India | ₹8.63 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Compass Pathways Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Compass Pathways Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Compass Pathways Plc (2018–2024)
The table below shows the annual total liabilities of Compass Pathways Plc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $58.97 Million | +17.37% |
| 2023-12-31 | $50.24 Million | +213.74% |
| 2022-12-31 | $16.01 Million | -2.86% |
| 2021-12-31 | $16.49 Million | +139.10% |
| 2020-12-31 | $6.89 Million | -71.12% |
| 2019-12-31 | $23.87 Million | -41.43% |
| 2018-12-31 | $40.75 Million | -- |